Assyro AI

FDA Orange Book · active-ingredient family

Fexofenadine hydrochloride; pseudoephedrine hydrochloride

Fexofenadine hydrochloride; pseudoephedrine hydrochloride is approved as 2 brand and 9 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

2

Brand (NDA)

9

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet, extended release

ProductApplicantApplicationTEApproved
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONRLDCHATTEM SANOFINDA 020786Jan 24, 2011
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTIONRLDCHATTEM SANOFINDA 021704Jan 24, 2011

Generic (ANDA) products (9)

ProductApplicantApplicationTEApproved
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEL PERRIGO COANDA 216792Oct 07, 2025
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEAUROBINDO PHARMA LTDANDA 215232Apr 17, 2025
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEDR REDDYSANDA 215434May 31, 2022
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEAUROBINDO PHARMAANDA 209116Oct 30, 2017
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDESUN PHARMANDA 090818Jan 29, 2015
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEDR REDDYSANDA 076667Nov 18, 2014
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEDR REDDYS LABS LTDANDA 079043Jun 22, 2011
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEIMPAX PHARMSANDA 076298Nov 12, 2010
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEBARRANDA 076236Apr 14, 2005

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Fexofenadine hydrochloride; pseudoephedrine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.